CHRISTINE A POON
CIK 1189014 · Vice Chairman · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$27.51M
Companies
6
Total Filings
198
Lifetime Open-Market Net
-$70.30M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRU | Director | 11,583 | $122.63 | $1.42M | $100.4K | 95 | 2026-06-15 |
| NBIX | Director | 4,753 | $180.79 | $859.3K | $0 | 5 | 2026-05-29 |
| REGN | Director | 5,219 | $695.42 | $3.63M | -$70.40M | 25 | 2026-01-06 |
| SHW | Director | 14,959 | $343.88 | $5.14M | $0 | 55 | 2025-04-07 |
| Decibel Therapeutics, Inc. (DBTX) Delisted | Director | — | $4.91 | — | $0 | 1 | 2021-02-16 |
| JNJ | Vice Chairman | 61,958 | $265.53 | $16.45M | $0 | 14 | 2009-02-17 |
Recent Filings · Page 7 of 20
198 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-10-13 | SHW | Grant (A) | +26 | $7.8K | EDGAR |
| 2021-09-20 | PRU | Grant (A) | — | $0 | EDGAR |
| 2021-08-31 | REGN | Mixed | — | -$9.16M | EDGAR |
| 2021-07-07 | SHW | Grant (A) | +28 | $7.8K | EDGAR |
| 2021-06-21 | PRU | Grant (A) | — | $0 | EDGAR |
| 2021-05-13 | PRU | Mixed | — | -$307.7K | EDGAR |
| 2021-04-07 | SHW | Grant (A) | +30 | $7.8K | EDGAR |
| 2021-03-15 | PRU | Grant (A) | — | $0 | EDGAR |
| 2021-02-18 | SHW | Grant (A) | +221 | $0 | EDGAR |
| 2021-02-16 | Decibel Therapeutics, Inc. (DBTX) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.